Letomore 2.5 Tablet contains Letrozole (2.5mg), an oral medication used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It belongs to a class of drugs known as aromatase inhibitors, which work by lowering estrogen levels in the body. Estrogen can promote the growth of some types of breast cancer cells, and by reducing its production, Letrozole helps to slow or stop the growth of these cancer cells.
Letomore is often prescribed as an adjuvant therapy following surgery, radiation, or chemotherapy, as well as in advanced cases of breast cancer to prevent recurrence. It can also be used to treat other types of hormonally responsive tumors. In some cases, it may be prescribed to help induce ovulation in women with infertility issues related to polycystic ovary syndrome (PCOS).
Letrozole works by inhibiting the enzyme aromatase, which is responsible for the production of estrogen in postmenopausal women. By blocking this enzyme, Letomore reduces the amount of estrogen in the body, which can be beneficial for the management of hormone-sensitive breast cancer. The reduction in estrogen levels also helps in managing symptoms related to certain gynecological conditions.
The tablet is usually taken once a day, with or without food. Dosage and treatment duration depend on the patient’s condition and response to therapy, and it should be taken under the supervision of a healthcare professional.